Pricing Log in Create free account

Immunic, Inc. (IMUX) vs PMV Pharmaceuticals, Inc. (PMVP)

Immunic, Inc. and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Immunic, Inc. and PMV Pharmaceuticals, Inc. are of similar size ($99.9M and $96.3M). Across the 8 metrics below, Immunic, Inc. leads on 4 and PMV Pharmaceuticals, Inc. on 4.

Valuation

Metric IMUX PMVP Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.60 0.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.16 0.66
EV/Sales n/m n/m 9.02
Earnings yield (56.15%) (113.60%) (32.88%)
Free cash flow yield (26.55%) (106.79%) (23.13%)

Profitability

Metric IMUX PMVP Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.17%) (70.93%) (51.96%)
Return on assets (101.15%) (64.04%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMUX PMVP Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 38.00% (29.82%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 7.70 4.97
Net debt to EBITDA 0.15 1.27 1.01

Dividend

Metric IMUX PMVP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMUX PMVP Biotechnology median
Market cap 99.88m 96.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack